Recombivax HB Related Published Studies
Well-designed clinical trials related to Recombivax HB (Hepatitis B Vaccine)
A randomized controlled phase IIb trial of antigen-antibody immunogenic complex therapeutic vaccine in chronic hepatitis B patients. [2008.07.02]
Economic evaluation of delivering hepatitis B vaccine to injection drug users. [2008.07]
A non-randomized vaccine effectiveness trial of accelerated infant hepatitis B immunization schedules with a first dose at birth or age 6 weeks in Cote d'Ivoire. [2008.05.23]
The development of a new heptavalent diphtheria-tetanus-whole cell pertussis-hepatitis B-Haemophilus influenzae type b-Neisseria meningitidis serogroups A and C vaccine: a randomized dose-ranging trial of the conjugate vaccine components. [2008.05]
Four is better than nine. a combined diphtheria-tetanus-pertussis-hepatitis B-Haemophilus influenzae type b vaccine for routine immunization in Malaysia. [2008.05]
CPG 7909 adjuvant plus hepatitis B virus vaccination in HIV-infected adults achieves long-term seroprotection for up to 5 years. [2008.04.15]
A new adjuvant improves the immune response to hepatitis B vaccine in hemodialysis patients. [2008.04]
Long-term antibody persistence induced by a combined hepatitis A and B vaccine in children and adolescents. [2008.03.25]
Vaccine adjuvant systems containing monophosphoryl lipid A and QS21 induce strong and persistent humoral and T cell responses against hepatitis B surface antigen in healthy adult volunteers. [2008.03.04]
Positive Impact of a Shelter-based Hepatitis B Vaccine Program in Homeless Baltimore Children and Adolescents. [2008.03]
Safety and immunogenicity of co-administered quadrivalent human papillomavirus (HPV)-6/11/16/18 L1 virus-like particle (VLP) and hepatitis B (HBV) vaccines. [2008.01.30]
Immunogenicity and safety of combined intradermal recombinant Hepatitis B with BCG vaccines at birth. [2008.01.30]
[A randomized controlled trial on effect of hepatitis B immune globulin in preventing hepatitis B virus transmission from mothers to infants] [2008.01]
One arm or two? Concurrent administration of meningococcal C conjugate and hepatitis B vaccines in pre-teens. [2008.01]
Safety and immunogenicity of a combined hepatitis B virus-Haemophilus influenzae type B vaccine comprising a synthetic antigen in healthy adults. [2008.01]
Therapeutic vaccination of chronic hepatitis B patients with virus suppression by antiviral therapy: a randomized, controlled study of co-administration of HBsAg/AS02 candidate vaccine and lamivudine. [2007.12.12]
Comparison of accelerated and rapid schedules for monovalent hepatitis B and combined hepatitis A/B vaccines in children with cancer. [2007.12]
Convenience is the key to hepatitis A and B vaccination uptake among young adult injection drug users. [2007.11]
Administration of hepatitis A vaccine at 6 and 12 months of age concomitantly with hexavalent (DTaP-IPV-PRP approximately T-HBs) combination vaccine. [2007.10.23]
Hepatitis B virus vaccine in lymphoproliferative disorders: a prospective randomized study evaluating the efficacy of granulocyte-macrophage colony stimulating factor as a vaccine adjuvant. [2007.10]
Primary vaccination of infants against hepatitis B can be completed using a combined hexavalent diphtheria-tetanus-acellular pertussis-hepatitis B-inactivated poliomyelitis-Haemophilus influenzae type B vaccine. [2007.10]
Immunogenicity and reactogenicity of two recombinant hepatitis B vaccines in small infants: a randomized, double-blind comparative study. [2007.10]
Comparative immunogenicity of 2 recombinant hepatitis B vaccines (GeneVac-B and Engerix-B) in adult patients with chronic renal failure. [2007.09]
Hepatitis B vaccination of newborn infants in rural China: evaluation of a village-based, out-of-cold-chain delivery strategy. [2007.09]
Phase I clinical trial in healthy adults of a nasal vaccine candidate containing recombinant hepatitis B surface and core antigens. [2007.09]
Concomitant administration of a virosome-adjuvanted hepatitis a vaccine with routine childhood vaccines at age twelve to fifteen months: a randomized controlled trial. [2007.09]
Cellular and humoral immune response to a third generation hepatitis B vaccine. [2007.08]
[Immunogenicity of vaccines against viral hepatitis A and B in the population above 40 years of age -- impact of risk factors] [2007.08]
Immunogenicity and safety of a pediatric dose of a virosome-adjuvanted hepatitis A vaccine: a controlled trial in children aged 1-16 years. [2007.08]
Immunogenicity and safety of a tetravalent measles-mumps-rubella-varicella vaccine co-administered with a booster dose of a combined diphtheria-tetanus-acellular pertussis-hepatitis B-inactivated poliovirus-Haemophilus influenzae type b conjugate vaccine in healthy children aged 12-23 months. [2007.08]
Immunogenicity and safety of a combination diphtheria, tetanus toxoid, acellular pertussis, hepatitis B, and inactivated poliovirus vaccine coadministered with a 7-valent pneumococcal conjugate vaccine and a Haemophilus influenzae type b conjugate vaccine. [2007.07]
Comparison of three different recombinant hepatitis B vaccines: GeneVac-B, Engerix B and Shanvac B in high risk infants born to HBsAg positive mothers in India. [2007.06.14]
Ten-year antibody persistence induced by hepatitis A and B vaccine (Twinrix) in adults. [2007.05]
Immunogenicity, reactogenicity and safety of two-dose versus three-dose (standard care) hepatitis B immunisation of healthy adolescents aged 11-15 years: a randomised controlled trial. [2007.04.12]
Immunogenicity and safety assessment of the Cuban recombinant hepatitis B vaccine in healthy adults. [2007.04]
Safety of a combination diphtheria, tetanus toxoid, acellular pertussis, hepatitis B, and inactivated polio vaccine coadministered with a 7-valent pneumococcal conjugate vaccine and a Haemophilus influenzae type b conjugate vaccine. [2007.02.26]
Predisposing, reinforcing and enabling factors associated with hepatitis B testing in Chinese Canadians in British Columbia. [2007.01]
Low dose intradermal vaccination is superior to high dose intramuscular vaccination for hepatitis B in unresponsive hemodialysis patients. [2007]
A controlled clinical trial comparing the safety and immunogenicity of a new adjuvanted hepatitis B vaccine with a standard hepatitis B vaccine. [2006.11.30]
Immunogenicity and safety assessment of the Cuban recombinant hepatitis B vaccine in healthy adults. [2006.10.20]
Immunogenicity and safety of an experimental adjuvanted hepatitis B candidate vaccine in liver transplant patients. [2006.10]
Antepartum immunoprophylaxis of three doses of hepatitis B immunoglobulin is not effective: a single-centre randomized study. [2006.09]
Immunogenicity and reactogenicity of primary immunization with a hexavalent diphtheria-tetanus-acellular pertussis-hepatitis B-inactivated polio-Haemophilus influenzae type B vaccine coadministered with two doses of a meningococcal C-tetanus toxoid conjugate vaccine. [2006.08]
Reactogenicity and immunogenicity profiles of a novel pentavalent diphtheria-tetanus-whole cell pertussis-hepatitis B and Haemophilus influenzae type B vaccine: a randomized dose-ranging trial of the Hib tetanus-conjugate content. [2006.08]
Efficacy of intradermal hepatitis B vaccination compared to intramuscular vaccination in hemodialysis patients. [2006.08]
Hepatitis A/B vaccination of adults over 40 years old: comparison of three vaccine regimens and effect of influencing factors. [2006.06.29]
Comparison of thiomersal-free and thiomersal-containing formulations of a recombinant hepatitis B vaccine (Hepavax-Gene) in healthy adults. [2006.06.19]
Immunological response to two hepatitis B vaccines administered in two different schedules. [2006.06]
Comparison of two hepatitis B vaccines (GeneVac-B and Engerix-B) in healthy infants in India. [2006.06]
Comparative immunogenicity of a PreS/S hepatitis B vaccine in non- and low responders to conventional vaccine. [2006.04.05]
Safety and immunogenicity of a measles, mumps, rubella and varicella vaccine given with combined Haemophilus influenzae type b conjugate/hepatitis B vaccines and combined diphtheria-tetanus-acellular pertussis vaccines. [2006.04]
Assessment of the compatibility of co-administered 7-valent pneumococcal conjugate, DTaP.IPV/PRP-T Hib and hepatitis B vaccines in infants 2-7 months of age. [2006.03.15]
Comparison of the safety and immunogenicity of hepatitis B virus surface antigen co-administered with an immunostimulatory phosphorothioate oligonucleotide and a licensed hepatitis B vaccine in healthy young adults. [2006.01.09]
A pilot study of SRL 172 (killed Mycobacterium vaccae) in healthy chronic hepatitis B carriers and hepatitis B vaccine non-responders. [2006.01]
Safety and immunogenicity of a primary course and booster dose of a combined diphtheria, tetanus, acellular pertussis, hepatitis B and inactivated poliovirus vaccine. [2006]
Immunogenicity and safety of an adjuvanted hepatitis B vaccine in pre-hemodialysis and hemodialysis patients. [2005.11]
Safety and immunogenicity of two formulations of a hexavalent diphtheria-tetanus-acellular pertussis-inactivated poliovirus-Haemophilus influenzae conjugate-hepatitis B vaccine in 15 to 18-month-old children. [2005.11]
Reactogenicity and immunogenicity profile of a two-dose combined hepatitis A and B vaccine in 1-11-year-old children. [2005.10.17]
[Comparative study on the protective effect of two immunization schemes using a hepatitis B recombinant vaccine in vulnerable health science students] [2005.10]
CPG 7909 adjuvant improves hepatitis B virus vaccine seroprotection in antiretroviral-treated HIV-infected adults. [2005.09.23]
Clinical safety and efficacy of a powdered Hepatitis B nucleic acid vaccine delivered to the epidermis by a commercial prototype device. [2005.09.23]
A new DTPw-HBV/Hib vaccine is immunogenic and safe when administered according to the EPI (Expanded Programme for Immunization) schedule and following hepatitis B vaccination at birth. [2005.09]
Comparative immunogenicity of a genetically derived and a plasma pooled hepatitis B vaccine in normal adult volunteers. [2005.05]
Low dose intradermal versus high dose intramuscular hepatitis B vaccination in patients on chronic hemodialysis. [2005.05]
Hepatitis B vaccination in a school age population: a feasibility study. [2005.05]
Lot-to-lot consistency of a combined hexavalent diptheria-tetanus-acellular-pertussis, hepatitis B, Inactivated polio and haemophilus B conjugate vaccine, administered to healthy chilean infants at two, four and six months of age. [2005.05]
Randomized trial of recombinant hepatitis B vaccine in HIV-infected adult patients comparing a standard dose to a double dose. [2005.04.22]
A two-dose schedule for combined hepatitis A and B vaccination in children aged 6-15 years. [2005.04.22]
Therapeutic effect of autologous dendritic cell vaccine on patients with chronic hepatitis B: a clinical study. [2005.03.28]
Immune response to an indigenously developed r-hepatitis B vaccine in mixed population: study of an accelerated vaccination schedule. [2005.02.21]
Safety and immunogenicity profile of an experimental hepatitis B vaccine adjuvanted with AS04. [2004.12.02]
The effect of concurrent use of hepatitis B and Bacille Calmette-Guerin vaccination on anti-hepatitis B response. [2004.12]
Hepatitis B vaccination associated with higher female than male mortality in Guinea-bissau: an observational study. [2004.12]
Antibody responses to intradermal recombinant hepatitis B immunization among HIV-positive subjects. [2004.11.25]
18-year follow-up study of a prospective randomized trial of hepatitis B vaccinations without booster doses in children. [2004.10]
Hepatitis B vaccination in prison with a 3-week schedule is more efficient than the standard 6-month schedule. [2004.09.28]
Immunogenicity and reactogenicity of two regimens of diphtheria-tetanus-acellular pertussis-hepatitis B-inactivated polio and Haemophilus influenzae type b vaccines administered to infants primed at birth with hepatitis B vaccine. [2004.09]
Immunogenicity of low dose intradermal hepatitis B vaccine and its comparison with standard dose intramuscular vaccination. [2004.09]
Immunogenicity of low-dose and conventional-dose recombinant hepatitis B vaccines in healthy adolescents in India. [2004.09]
Efficacy of hepatitis B vaccination and interferon-alpha-2b combination therapy versus interferon-alpha-2b monotherapy in children with chronic hepatitis B. [2004.07]
Safety, reactogenicity and immunogenicity of a combined hexavalent tetanus, diphtheria, acellular pertussis, hepatitis B, inactivated poliovirus vaccine and Haemophilus influenzae type b conjugate vaccine, for primary immunization of infants. [2004.06.02]
Efficacy and side effects of intradermal hepatitis B vaccination in CAPD patients: a comparison with the intramuscular vaccination. [2004.05]
Granulocyte macrophage colony stimulating factor augmented hepatitis B vaccine protocol for rapid seroprotection in voluntary kidney donors. [2004.04]
Concomitant administration of a bivalent Haemophilus influenzae type b-hepatitis B vaccine, measles-mumps-rubella vaccine and varicella vaccine: safety, tolerability and immunogenicity. [2004.03]
Effect of maternal antibody on immunogenicity of hepatitis A vaccine in infants. [2004.03]
Simultaneous vaccination against hepatitis A and B: results of an open, randomized study from the occupational health point of view. [2004]
High seroprotection rate induced by intradermal administration of a recombinant hepatitis B vaccine in young healthy adults: comparison with standard intramuscular vaccination. [2004]
Immune response of intradermal hepatitis B vaccination at lower dose versus intramuscular vaccination at double standard dose in predialytic chronic renal failure patients. [2003.12]
Immune response to hepatitis B vaccine in asthmatic children. [2003.12]
Efficacy of granulocyte-macrophage colony-stimulating factor (GM-CSF) as a vaccine adjuvant for hepatitis B virus in patients with HIV infection. [2003.11.07]
[Comparison of two different vaccination schemes against Hepatitis A and B in Mexican children and adolescents.] [2003.10]
[Immunogenicity and efficacy of a new recombinant DNA vaccine for hepatitis B virus in Peru] [2003.10]
Comparison of the reactogenicity and immunogenicity of a combined diphtheria, tetanus, acellular pertussis, hepatitis B, inactivated polio (DTPa-HBV-IPV) vaccine, mixed with the Haemophilus influenzae type b (Hib) conjugate vaccine and administered as a single injection, with the DTPa-IPV/Hib and hepatitis B vaccines administered in two simultaneous injections to infants at 2, 4 and 6 months of age. [2003.09.08]
False positive HBsAg result in blood donors due to administration of three different recombinant DNA Hepatitis B vaccines. [2003.09.08]
Hepatitis A and B vaccination in a sexually transmitted disease clinic for men who have sex with men. [2003.09]
A randomized controlled trial of monetary incentives vs. outreach to enhance adherence to the hepatitis B vaccine series among injection drug users. [2003.08.20]
Specific hepatitis B vaccine therapy in inactive HBsAg carriers: a randomized controlled trial. [2003.08]
Immunogenicity of 10 and 20 microgram hepatitis B vaccine in a two-dose schedule. [2003.07.04]
Intramuscular versus intradermal administration of anti-hepatitis B vaccine in non-cirrhotic hepatitis C patients. [2003.06.20]
Nature, evolution, and appraisal of adverse events and antibody response associated with the fifth consecutive dose of a five-component acellular pertussis-based combination vaccine. [2003.06.02]
Successful promotion of hepatitis B vaccinations among Vietnamese-American children ages 3 to 18: results of a controlled trial. [2003.06]
|
